RNA polymerase I-driven reverse genetics system for enterovirus 71 and its implications for vaccine production

Virology Journal

Volumn 9, Issue , 2012, Pages

  Meng, Tao ^a   Kiener, Tanja K ^a   Kwang, Jimmy ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Enterovirus 71; Reverse genetics; Universal RT PCR; Vaccine

Indexed keywords

DNA DIRECTED RNA POLYMERASE; ENTEROVIRUS VACCINE; INACTIVATED VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; REVERSE GENETICS; VACCINE PRODUCTION; VERO CELL; VIRAL GENETICS; VIROGENESIS; VIRUS GENOME; WILD TYPE;

ANIMALS; CERCOPITHECUS AETHIOPS; CYTOPATHOGENIC EFFECT, VIRAL; ENTEROVIRUS A, HUMAN; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; REVERSE GENETICS; RNA POLYMERASE I; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; VERO CELLS; VIRAL VACCINES;

HUMAN ENTEROVIRUS 71; POLIOVIRUS;

EID: 84867466704     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-238     Document Type: Article

References (25)

1. Enteroviruses: poliovirus, coxsackieviruses, echoviruses, and newer enteroviruses. Pallansch MA, Roos RP, Fields virology Philadelphia, PA: Lippincott Williams & Wilkin, Knipe DM, Howley PM, Griffin DE, Martin MA, Lamb RA, Roizman B, 4 2000 723 775 vol. 1
2. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Mong HO, Lancet Infect Dis 2010 10 778 790 10.1016/S1473-3099(10)70194-8 20961813
3. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Brown BA, Pallansch MA, Virus Res 1995 39 195 205 10.1016/0168-1702(95)00087-9 8837884
4. Revolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene. Tee KK, Lam TT, Chan YF, Bible JM, Kamarulzaman A, Tong CY, Takebe Y, Pybus OG, J Virol 2010 84 3339 3350 10.1128/JVI.01019-09 20089660
5. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. Brown BA, Oberste MS, Alexander JP, Kennett ML, Pallansch MA, J Virol 1999 73 9969 9975 10559310
6. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. Mcminn P, Lindsay K, Perara D, Chan HM, Chan KP, Cardosa MJ, J Virol 2001 75 7732 7738 10.1128/JVI.75.16.7732-7738.2001 11462047
7. Frequency and dynamics of recombination within different species of human enteroviruses. Simmonds P, Welch J, J Virol 2006 80 483 493 10.1128/JVI.80.1.483-493.2006 16352572
8. Analysis of recombination and natural selection in human enterovirus 71. Chen X, Zhang Q, Li J, Can W, Zhang JX, Zhang L, Zhang W, Shao ZJ, Yan Y, Virol 2010 398 251 261 10.1016/j.virol.2009.12.007
9. Enterovirus 71 infections and neurologic disease-United States, 1977-1991. Alexander JP, Baden L, Pallansch MA, Anderson LJ, J Infect Dis 1994 169 905 908 10.1093/infdis/169.4.905 8133108
10. Clinical features, diagnosis and management of human enterovirus 71 infection. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T, Lancet Neurol 2010 9 1097 1105 10.1016/S1474-4422(10)70209-X 20965438
11. EV71: an emerging infectious disease vaccine target in the far east? Xu J, Qian Y, Wang SX, Serrano JG, Li W, Huang ZH, Lu S, Vaccine 2010 28 3516 3521 10.1016/j.vaccine.2010.03.003 20304038
12. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. Ong KC, Devi S, Cardosa MJ, Wong KT, J Virol 2010 84 661 665 10.1128/JVI.00999-09 19864378
13. Selection and characterization of vaccine strain for enterovirus 71 vaccine development. Chang JY, Chang CP, Tsai HH, Lee CD, Lian WC, Su IJ, Sai IH, Liu CC, Chou AH, Lu YJ, Chen CY, Lee PH, Chiang JR, Chong PC, Vaccine 2012 30 703 711 10.1016/j.vaccine.2011.11.087 22142585
14. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. Arita M, Shimizu H, Nagata N, Ami Y, Suzaki Y, Sata T, Iwasaki T, Miyamura T, J Gen Virol 2005 86 1391 1401 10.1099/vir.0.80784-0 15831951
15. Producing infectious enterovirus type 71 in a rapid strategy. Han JF, Cao RY, Tian X, Yu M, Qin ED, Qin CF, Virol J 2010 7 116 120 10.1186/1743-422X-7- 116 20525351
16. A DNA transfection system for generation of influenza a virus from eight plasmids. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG, Proc Natl Acad Sci USA 2000 97 6108 6113 10.1073/pnas.100133697 10801978
17. Recovery of infectious foot-and-mouth disease virus from full-length genomic cDNA clones using RNA polymerase i system. Chang Y, Zheng H, Shang Y, Jin Y, Wang G, Shen X, Liu X, Acta Biochem Biophys Sin 2009 41 998 1007 10.1093/abbs/gmp093
18. Display of VP1 on the surface of baculovirus and its immunogenicity against heterologous human enterovirus 71 strains in mice. Meng T, Kolpe AB, Kiener TK, Chow VT, Kwang J, PLoS One 2011 6 21757 10.1371/journal.pone.0021757 21747954
19. Generation of an infectious cDNA clone of an FMDV strain isolated from swine. Liu G, Liu Z, Xie Q, Chen Y, Bao H, Chang H, Liu X, Virus Res 2004 104 157 164 10.1016/j.virusres.2004.04.002 15246653
20. Neorovirulence determinants of genetically engineered Theiler viruses. Fu J, Stein S, Rosenstein L, Bodwell T, Routbort M, Semler BL, Ross RP, Proc Nati Acad Sci USA 1990 87 4125 4129 10.1073/pnas.87.11.4125
21. Full-length cDNA synthesis for long-distance RT-PCR of large mRNA transcripts. Hawkins PR, Jin P, Fu GK, Biotechniques 2003 34 768 773 12703302
22. Role of 3-end sequences in infectivity of poliovirus transcripts made in vitro. Sarnow P, J Virol 1989 63 467 470 2535751
23. High efficiency T7 polymerase synthesis of infectious RNA from cloned brome mosaic virus cDNA and effects of 5 entensions on transcript infectivity. Janda M, French R, Ahlquist P, Virology 1987 158 259 262 10.1016/0042-6822(87) 90265-0 18644564
24. Purification and characterization of enterovirus 71 viral particles produced from Vero cells grown in a serum-free microcarrier bioreactor system. Liu CC, Guo MS, Lin FH, Hsiao KN, Chang KH, Chou AH, Wnag YC, Yang CS, Chong PC, PLoS One 2011 6 20005 10.1371/journal.pone.0020005 21603631
25. Nicolson C.,Major D.,Wood J.M.,Robertson J.S., Generation of influenza vaccine viruses on Vero cells by reverse genetics: An H5N1 candidate vaccine strain produced under a quality system, Vaccine, 2005, 23, 2943-2952